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Summary
Anestimateofcancerdeathsandincidencefortheyears 1997 and2002, takingaccountofcurrent
trends and population projections for Northern Ireland is presented below. These numbers will
be of value to those planning services and, in particular, for those implementing the report
"Cancer Services -Investing for the Future".' Cancer deaths are expected to rise by almost 13%
to 4056 by the year 2002. Marked rises are expected in the number ofdeaths from cancer ofthe
lung, oesophagus, kidney, bladder and prostate with smaller rises in deaths from breast and
pancreatic cancer.
The fall in stomach cancer is expected to continue as is the trend of lower deaths from cervical
cancer. Deaths from cancer of the colon and rectum are expected to remain static. Estimates of
cancer incidence currently and for the years 1997 and 2002 are also included. The impact of
tobacco use by the population, which poses a current and future serious threat to public health
is highlighted.
INTRODUCTION
In April 1995, following wide consultation, the
Secretary ofState for Health unveiled a strategic
framework for the future development ofcancer
services This was based on a policy framework
for commissioning cancer services: "A report by
the Expert Advisory Group on Cancer to the
Chief Medical Officers of England and Wales"
(theCalmanReport).2TheExpertAdvisory Group
consideredevidenceregardingthecurrentposition
of cancer services in England and Wales and
made recommendations. These were to ensure
equal access to high quality cancer care for all
people, irrespective of where they live. It was
recommended that cancer services should be
organised as a network which included primary
care and care in the community, secondary care
inDistrictGeneralHospitals,designatedascancer
units, with tertiary care provided in large cancer
centres. Thecancerunitandcancercentreswould
be closely integrated with good communication
between the three levels of care.
The Department ofHealth and Social Services in
Northern Ireland established a Cancer Working
Group under the chairmanship of the Chief
Medical Officer, Dr Henrietta Campbell. Their
remit was to consider how the recommendations
oftheExpertAdvisory Group's reportmightbest
be implemented in Northern Ireland. The Cancer
Working Group's report "Cancer Services -
Investing for the Future"' includes recom-
mendations which emphasise multidisciplinary,
multiprofessional team management ofpatients,
and effective communication between the newly
designatedcancercentre,cancerunitsandprimary
care. Unfortunately, the absence of accurate
information on the numbers ofcancers occurring
in the population could hamper the planning of
these important changes. Incidence data will be
availablefromthere-establishedCancerRegistry
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Group. Anyone working onplanning services for
haematological malignancies, colorectal cancer
and malignant melanoma can thank those far-
sighted enough to establish disease-specific
registriesforthesetumours.TheN.IrelandCancer
Registry has already produced trends for cancer
deaths over the past 25 years.3 This has given a
basisfromwhichtoestimatethenumberofcancer
deathsandfurtherextrapolate anexpectednumber
of cancers in various major groups for Northern
Ireland.
METHODS
The trends in the World Health Organisation age
standardisedmortality rates4foreach sex andage
band were calculated for those under 65 years
and those over 65 years. The standard errors of
these trends were also calculated. The average
age-specific rates for the two age groups (under
and over 65 years) were calculated using deaths
1985-1993 and the 1991 mid year population
estimates.5 This was to produce the reference
points to which the trends would be applied. The
historical trends were applied to the 1991 rates
and extrapolated forward to 1997 and 2002 to
produce the expected number of deaths in those
years. 95% confidence intervals were calculated
for each year using the standard error ofthe beta
co-efficient of the regression lines to provide an
estimate of the variation associated with the
projections. Thesewerescaledup,usingincidence
to mortality ratios,6'7 to estimate the numbers of
new cases per year.
RESULTS
It is estimated that by 2002 the total number of
cancerdeaths will haverisen by 13%, from 3,595
(the average 1989-1993) to4,056. (SeeFigure 1).
The number of lung cancer deaths will rise by
30% to 1,033. The fall in deaths in men under 65
from 160 to 129 will be offset by an increase in
deathsamongoldermenandwomen(seeTable I).
Thenumberoflungcancersdiagnosedisexpected
to rise from current estimates of 953 to 1,239 by
2002 (see Table II). The fall in levels among
younger men will again be offset by the rise in
levels among older men and both older and
younger women.
Deaths from cancer of the oesophagus are
expected to rise 35% by 2002 to 157. The biggest
increases will be in youngermen while in women
the rise will be mainly in those over 65, giving
rise to an expected 58 female oesophageal cancer
deaths.
Figure 1
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New cases diagnosed are expected to rise to 181
per year by 2002 (see Table I).
Cancer of the stomach should continue to fall so
that by 2002 there should be 104 male cancer
deaths and 59 stomach cancer deaths in women
(see Figure 2 and Table I). The numbers of
stomach cancers diagnosed is also expected to
fall to 212 by 2002 (see Table II).
The number of deaths from cancers of the colon
and rectum are expected to remain unchanged
over this period. A fall in deaths among older
women and, to a lesser extent amongst younger
women is predicted to be offset by the rise in
deaths of older men (see Table I).
Deaths from cancer ofthe pancreas are expected
to rise by about 4% to 165 per year with 190 new
cases predicted in 2002 (see Tables I & II).
Deaths from breast cancer are expected to rise by
8.6% to 342 by the year 2002 though the
confidence intervals in this are fairly wide. New
cases diagnosed each year are expected to rise
from an estimated 630 in 1991 to 685 by the year
2002. Deaths from cancer ofthe cervix which are
showing a downward trend may fall further by
2002 (see Figure 3 and Table III).
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TABLE I
Estimated deathsfrom selected cancers in N. Ireland 1997 and 2002
Male Female Total
Current Current Current
Annual Annual Annual
Average Predicted Predicted Average Predicted Predicted Average Predicted Predicted
Site ICD Age 1989-93 1997 2002 1989-93 1997 2002 1989-93 1997 2002 95% CI±
Oesophagus 150 <65 25 32 38 6 6 6 31 38 44 0
>65 43 53 61 41 48 52 85 100 113 12
Total 68 84 99 48 54 58 116 138 157 12
Stomach 151 <65 36 29 25 17 13 11 53 43 35 4
>65 93 86 80 75 59 48 168 145 128 9
Total 129 116 104 92 72 59 221 187 163 13
Colon 153 <65 40 41 42 36 34 33 76 75 74 2
>65 112 119 123 149 144 138 261 263 261 9
Total 152 160 165 185 178 171 337 338 336 11
Rectum 154 <65 18 18 18 11 10 9 29 28 28 1
>65 51 54 56 39 35 31 90 89 88 2
Total 69 73 75 50 45 40 119 117 115 3
Pancreas 157 <65 22 20 18 19 19 19 40 39 37 1
>65 53 57 58 65 68 69 118 124 127 0
Total 75 76 77 84 87 88 158 163 165 1
Lung 162 <65 160 144 129 71 83 91 232 227 220 27
>65 391 446 490 171 250 323 563 697 813 40
Total 552 590 619 243 333 413 794 923 1033 65
Bladder 188 <65 12 12 12 40 42 42 52 54 54 0
>65 51 57 61 47 49 50 98 1906 111 5
Total 62 69 73 88 91 92 150 160 165 5
Kidney 189 <65 16 17 17 1 2 2 17 18 19 0
>65 26 32 39 10 13 16 36 45 54 5
Total 42 49 55 11 15 18 53 64 73 5
All Cancers <65 536 536 527 527 543 547 1063 1079 1074 11
>65 1320 1480 1602 1212 1319 1380 2532 2799 2982 64
Total 1856 2017 2129 1738 1861 1927 3595 3878 4056 75
Deaths from cancer of the kidney and renal
parenchyma (ICD 189) are expected to rise by
39% from 53 in 1991 to 73 in 2002. Most ofthis
increase will be accountedforby acontinued rise
in deaths in older men (see Figure 4 and Table I).
It is calculated there will be 132 new cases of
kidney cancer diagnosed in the year 2002 (see
Table II).
Deaths from cancer of the prostate are expected
to rise by 20% to 219 by the year 2002. This
increase based on current trends (see Figure 5)
will be totally in men over 65. The predicted
number of new cases diagnosed is 416 for the
year 2002 (see Table III).
Deaths from bladder cancer are predicted to rise
by 10% to 165 in the same period. This increase
will belargely inmen over65. Itisexpectedthere
will be496 new cases ofthis cancerdiagnosedby
the year 2002.
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TABLE II
Estimated incidence ofselected cancers in N. Ireland 1997 and 2002
Male Female
109
Tota
Estimated Predicted Predicted Estimated Predicted Predicted Estimated Predicted Predicted
ICD Age 1993 1997 2002 1993 1997 2002 1993 1997 2002 95% CI±
150 <65 29 36 43 7 7 7 36 44 51 1
>65 50 61 70 48 55 60 98 116 130 14
Total 79 97 114 55 62 67 133 159 181 15
151 <65 47 38 32 22 17
>65 121 112 103 97 76
Total 168 150 135 119 93
14 69 55 46
63 218 188 166
77 287 244 212
153 <65 54 56 56 48 46 44 102 102 100
>65 151 161 167 201 194 186 352 355 353
Total 205 217 223 249 240 230 454 457 453
154 <65
>65
Total
21 22 22 13
61 65 68 47
83 87 90 60
157 <65 25 23
>65 61 65
Total 86 88
21
67
88
12 11 35 34 33
42 38 108 107 105
54 49 143 141 138
21 22 22 46 45 43
75 78 79 136 143 147
96 100 101 182 188 190
162 <65 192 173 155 86 99 109 278 272 264
>65 469 536 589 206 300 387 675 836 976
Total 662 708 743 291 399 496 953 1108 1239
188 <65 35 36 37 121 125 126 156 161 162
>65 152 170 183 142 148 151 295 318 334
Total 187 206 219 263 273 277 451 479 496
2
3
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16
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TABLE III
Estimated deaths and incidencefrom cancers ofthe breast, cervix and
prostate in N. Ireland 1997 and 2002
Deaths Incidence
Estimated Predicted Predicted Estimated Predicted Predicted
Site ICD Age 1993 1997 2002 95% CI± 1993 1997 2002 95% CI±
Breast 174 <65 148 159 165 11 296 318 330 21
(female) >65 167 175 177 0 334 349 354 0
Total 315 334 342 11 630 667 685 21
Cervix 180 <65 21 18 17 3 56 50 45 7
>65 16 15 13 2 43 39 36 6
Total 37 33 30 5 99 89 82 13
Prostate 185 <65 15 15 15 0 28 29 29 0
>65 168 188 204 13 319 357 387 25
Total 182 203 219 13 347 386 416 25
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Figure 2
TRENDS IN AGE STANDARDISED MORTAUTY RATES (65 YEARS
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N.IRELAND 1969-93
200
1501
LU
100
LU
00
| FEMALE (>66) | NB 80Yo OF-
Linear (FMALE (>65)) | D5 EATHSOCRI
*fJ{ 1973 1977 1981 1985 1989 1993
YEAR
Figure 4
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Figure 3
TRENDS IN AGE STANDARDISED MORTALITY RATES
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Figure 5
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DISCUSSION
Planningforthefuture isfraughtwith difficulties
though itis bettertobest-guess than nottoplan at
all. Itis important, however, thattheassumptions
built into a planning model are explicit so that
theycanbechallengedandifnecessarymodified.
The assumptions used to calculate the deaths and
numbers of new cases are as follow:
1. That the population projections are correct.
2. Thatthetrends in cancermortality rates, over
theprevious25 years 1969-1993,forNorthern
Ireland continue into the near future.
3. That the ratios for incidence to mortality (the
numberofnewcasesperyearcomparedtothe
numberofthose whodiedfromthecancer) do
notaltersignificantlyandtheNorthernIreland
population has similar characteristics to the
Welsh and Scottish populations.
Thisanalysistakesintoaccountprojectedchanges
in the population albeit at the safer aggregate
levels of over and under 65 years.
The number of cancers in a population is
dependent on the incidence rate and the size and
age structure of that population. It is estimated
that the population ofN. Ireland will increase by
4.8% between 1991 and 20025 (5.5% for males
and 4.2% for females). This alone will increase
the numbers ofcancers and cancer deaths. Other
things being equal, an older population will
generate morecases, ascancerislargely adisease
ofolder ages. The population ofN. Ireland is not
only increasing but it is also becoming older.
Between 1991 and 2002 the number of males
over 65 are predicted to increase by 10.8%,
females by 6.0%.
Almost halfofthe anticipated increase in female
cancer deaths and 60% cancer deaths in males
willbeduetodemographicchange. Theremainder
is mostly due to risk factor change, although the
interaction between demography and risk will
account for approximately 2.5% and 4.5%
respectively.
An important premise is that the incidence to
mortality ratio shouldremain constant. Onlytime
will tell if this was valid. It is possible that risk
factor change may affect both incidence and
survivorship and that new therapies and/or better
organisation of cancer services may reduce
mortality rates independently of incidence rate
change. Also,thecalculations cannottake account
of newer methods of diagnosing cancers which
may becomecommon-placeby theyear2002. An
example of this would be the use of Prostatic
Specific Antigen in the detection of prostatic
cancer. This would increase the numbers of
prostatic cancers diagnosed, althoughexperience
from elsewhere indicates that the death rates
fromthedisease wouldnotbeaffected.8 The20%
increase in prostatic cancer deaths predicted
reflects the-changing numbers and age structure
ofthepopulation. Therisein breastcancerdeaths
by 8.6% is also largely due to demographic
changeswithmoreolderwomeninthepopulation.
The calculation has not taken account of the
possibleimpactoftheN.IrelandBreastScreening
Programme which aims to reduce breast cancer
deaths by 25% in the screened population by
2002 (estimated deaths prevented at 20peryear).
The standardised mortality ratio 1980-1992 for
breast cancer, which takes age into account, fell
from 27.7 to 24.5 while the numbers of deaths
rose by 41 to 331 deaths by 1993.3
The predicted rise in deaths from cancer of the
lung, oesophagus, pancreas and bladder reflects
not only the changing demography but is also a
legacy from the use oftobacco in previous years.
It is known there is an approximately 20 year lag
between tobacco use and the development of
lung cancer in a population.9 The patterns of
tobaccouseinthe 1980'sshould, withpopulation
changes, determine the rise or fall in numbers of
tobacco-related cancers in the early 21stcentury.
There has been a reduction in the prevalence of
smoking in N. Ireland, yet in 1994 almost athird,
31% ofmen and32% ofwomen, wererecordedas
current smokers, higher than 28% for England
and Wales. Smoking levels were highest in the
age group 35-54 where 42% of men and 39% of
women smoked. These smokers, especially the
women tended to smoke more than the average.
Tobacco-related cancers may also occur in the
population of ex-smokers. In 1994 half of men
and a quarter of women aged 55-74 were ex-
smokers as were 26% ofmen and 19% ofwomen
aged 35-54.10
Thetrendofrisingdeathsfromlungcanceramong
young women more than offsets the health gain
achieved by falling tobacco use by younger men.
This is likely to continue. Currently 27% ofmen
and 33% ofwomen aged 16-34 are smokers. This
identifies an area for urgent attention to protect
the health of the population in N. Ireland and
achieve the targets of the N. Ireland Regional
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Strategy for reduction in lung cancers." The
target for 2010 is to reduce the death rate from
lung cancer by at least 30% in men under 75 and
15% in women under 75.
The need for accurate incidence information on
cancer, amajordisease group which accounts for
23% of deaths, over 20,000 hospital admissions
and an unmeasured amount of health service
resources is again highlighted. We look forward
to the time when the N. Ireland Cancer Registry
isregularlyproducingtimelyaccurateinformation
on cancer in N. Ireland for the purposes of
research, education and planning of services. In
themeanwhilethesepredictions shouldassistthe
N. Ireland Cancer Working Group in making
decisions on the future of cancer services and
enhance the precision of data available to those
planning cancer services.
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